Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis
Curtis L Cooper1, Eric Druyts2, Kristian Thorlund3, Jean B Nachega4, Antoine C El Khoury5, Christopher O'Regan6, Edward J Mills2,31Division of Infectious Diseases, Faculty of Medicine, 2Faculty of Health Sciences, University of Ottawa, Ottawa, 3Department of Clinical Epidemiology and Biostat...
Saved in:
Main Authors: | Cooper CL (Author), Druyts E (Author), Thorlund K (Author), Nachega JB (Author), El Khoury AC (Author), O'Regan C (Author), Mills EJ (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2012-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection
by: El Khoury AC, et al.
Published: (2012) -
Boceprevir and telaprevir utilization evaluation for the treatment of chronic hepatitis C
by: P. Marrero-Álvarez, et al.
Published: (2014) -
Telaprevir or Boceprevir for Hepatitis C treatment: a first survey of pharmacoutilization
by: Maurizio eCapuozzo, et al.
Published: (2013) -
Rapid virological response of telaprevir and boceprevir in a Brazilian cohort of HCV genotype 1 patients: a multicenter longitudinal study
by: Borba HHL, et al.
Published: (2017) -
Boceprevir and personalized medicine in hepatitis C virus infection
by: Habersetzer F, et al.
Published: (2012)